For the second time in 16 months, Unity Biotechnology is restructuring its operations. The developer of drugs to treat diseases of aging is cutting its headcount in half to ensure its cash reserves ...
Unity will merge with ironSource in an all-stock transaction that values the latter at $4.4 billion. If you perform a Control-F search for the word “synergy” (and “synergies”) on a transcript of the ...
Join our daily and weekly newsletters for the latest updates and exclusive content on industry-leading AI coverage. Learn More Over the last couple of decades, world mapping and representation in the ...
UNITY Biotechnology, Inc. has announced that it will present data from its ASPIRE Phase 2B study on its senolytic candidate, UBX1325, targeting diabetic macular edema at the upcoming ARVO 2025 Annual ...
Hosted on MSN
Unity's New Ad Solutions Drive Stock to 52-Week High
Unity Software (NYSE: U) gave investors a reason to take notice in mid-July 2025. The company's stock jumped over 14% to a new 52-week high. Unity's stock price jump was powered by a trading volume of ...
Unlocking an “Aladdin’s cave” of Medicare data is the key to saving Australia’s celebrated health system and changing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback